Mitigation and Management of Ocular Toxicity in Patients Receiving Antibody–Drug Conjugates

Learn how ophthalmologists and optometrists can work with hematologist/oncologists to recognize and optimally manage ocular toxicities in patients receiving antibody&ndash drug conjugates for the treatment of cancer with expert slides and on-demand Webcast capturing a live CCO Webinar plus a focused expert-authored commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

GlaxoSmithKline